Regeneron Pharmaceuticals (Nasdaq: REGN) is a biopharmaceutical company that discovers, develops, and intends to commercialize pharmaceutical products for the treatment of serious medical conditions.
Recent Mentions on Fool.com
- Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too
- Why Novartis and Regeneron Care About This Tiny Biotech Stock
- 3 Crashing Stocks: Is 1 a Buy?
- Regeneron Pharmaceuticals Inc Stock Racks Up Another Win
- Great Cholesterol Drug Data From Regeneron Pharmaceuticals Inc. and Sanofi SA, but Read the Fine Pri